151 related articles for article (PubMed ID: 37860497)
1. Retracted: METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9815081. PubMed ID: 37860497
[TBL] [Abstract][Full Text] [Related]
2. METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m
Hu S; Song Y; Zhou Y; Jiao Y; Li G
J Healthc Eng; 2022; 2022():5794422. PubMed ID: 35392146
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.
Chen WW; Qi JW; Hang Y; Wu JX; Zhou XX; Chen JZ; Wang J; Wang HH
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4263-4270. PubMed ID: 32373962
[TBL] [Abstract][Full Text] [Related]
4. Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):4947. PubMed ID: 35916787
[TBL] [Abstract][Full Text] [Related]
5. m
Chen J; Zhang YC; Huang C; Shen H; Sun B; Cheng X; Zhang YJ; Yang YG; Shu Q; Yang Y; Li X
Genomics Proteomics Bioinformatics; 2019 Apr; 17(2):154-168. PubMed ID: 31154015
[TBL] [Abstract][Full Text] [Related]
6. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
[TBL] [Abstract][Full Text] [Related]
7. Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9813487. PubMed ID: 37810561
[TBL] [Abstract][Full Text] [Related]
8. METTL3 promotes inflammation and cell apoptosis in a pediatric pneumonia model by regulating EZH2.
Yang Y; Yang X; Wu Y; Fu M
Allergol Immunopathol (Madr); 2021; 49(5):49-56. PubMed ID: 34476922
[TBL] [Abstract][Full Text] [Related]
9. Retracted: circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.
Markers D
Dis Markers; 2023; 2023():9757632. PubMed ID: 37564088
[TBL] [Abstract][Full Text] [Related]
10. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.
Ouyang D; Hong T; Fu M; Li Y; Zeng L; Chen Q; He H; Wen Y; Cheng Y; Zhou M; Zou Q; Yi W
Breast Cancer Res; 2023 Feb; 25(1):19. PubMed ID: 36765397
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
12. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
13. Retracted: si-PDGFR
Longevity OMAC
Oxid Med Cell Longev; 2024; 2024():9839740. PubMed ID: 38236530
[TBL] [Abstract][Full Text] [Related]
14. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
[TBL] [Abstract][Full Text] [Related]
15. METTL3-mediated m
Cheng C; Wu Y; Xiao T; Xue J; Sun J; Xia H; Ma H; Lu L; Li J; Shi A; Bian T; Liu Q
Mol Ther Nucleic Acids; 2021 Mar; 23():487-500. PubMed ID: 33510938
[TBL] [Abstract][Full Text] [Related]
16. METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m
Li J; Yao H; Huang J; Li C; Zhang Y; Xu R; Wang Z; Long Z; Tang J; Wang L
Cell Death Dis; 2022 Aug; 13(8):723. PubMed ID: 35985997
[TBL] [Abstract][Full Text] [Related]
17. Retracted: EZH2 Regulates ANXA6 Expression via H3K27me3 and Is Involved in Angiotensin II-Induced Vascular Smooth Muscle Cell Senescence.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9791678. PubMed ID: 38188996
[TBL] [Abstract][Full Text] [Related]
18. RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.
Li Y; Wang NX; Yin C; Jiang SS; Li JC; Yang SY
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077054
[TBL] [Abstract][Full Text] [Related]
19. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics.
Liu H; Huang Y; Lu S; Yuan D; Liu J
Open Life Sci; 2023; 18(1):20220586. PubMed ID: 36970605
[TBL] [Abstract][Full Text] [Related]
20. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m
Zhao W; Cui Y; Liu L; Ma X; Qi X; Wang Y; Liu Z; Ma S; Liu J; Wu J
Mol Ther Nucleic Acids; 2020 Jun; 20():1-12. PubMed ID: 32145676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
